Webinar: Psychedelic Medicines
July 2024
In March 2024 the European Medicines Agency organised a workshop on the research and development of psychedelic medicines in Europe. Their products have been tested against several mental conditions, including depression, severe anxiety, attention deficit hyperactivity disorder, autism spectrum disorder, and post-traumatic stress disorder.
Could these treatments also help against mental health conditions associated with your disease? What clinical research is currently underway? What are the legal or scientific obstacles? Which initiatives could we join? The webinar will address these questions, and will also feature guest speaker Tadeusz Hawrot, Founder and Executive Director of Psychedelic Access and Research European Alliance.
?Psychedelic Medicines: Is there potential for psychedelic medicines for my disease?
➡️ Register now!
?️ 24 July 2024
⏰ 4PM CET